Literature DB >> 18239157

Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts.

Gregory T Jones1, Andrew R Thompson, Frank M van Bockxmeer, Hany Hafez, Jackie A Cooper, Jonathan Golledge, Stephen E Humphries, Paul E Norman, Andre M van Rij.   

Abstract

OBJECTIVE: Although polymorphic variations in genes of the RAS system have previously been associated with susceptibility to AAA, such studies have been significantly limited by small sample sizes. This study was undertaken, using the largest case series yet reported, to determine whether common genetic variants of the RAS are associated with either susceptibility or severity of AAA. METHODS AND
RESULTS: The frequencies of 4 common genetic variants of genes related to the renin-angiotensin system were investigated in 3 geographically distinct, but ethnically similar, case-control cohorts, resulting in comparison of 1226 AAA cases with 1723 controls. In all 3 the AGTR1 1166C allele was significantly more common in AAA patients than controls (overall adjusted OR 1.60, 95% CI 1.32 to 1.93, P=1.1x10(-6)). Overall, the ACE ID genotype was associated with AAA (OR 1.33, 95% CI 1.06 to 1.67, P<0.02). The AGT 268T allele appeared to have an epistatic effect on large aneurysm size.
CONCLUSIONS: This study has identified a strong and repeated association between the AGTR1 1166C allele and susceptibility to AAA, and a weaker effect associated with the ACE deletion allele, in 3 geographically distinct, but ethnically similar, case-control cohorts. This study highlights the key role of the RAS in AAA and emphasizes the need for replication and validation of results in suitable independent cohorts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239157      PMCID: PMC2775049          DOI: 10.1161/ATVBAHA.107.155564

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  36 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

Review 2.  Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis.

Authors:  A R Thompson; F Drenos; H Hafez; S E Humphries
Journal:  Eur J Vasc Endovasc Surg       Date:  2007-10-24       Impact factor: 7.069

3.  The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators.

Authors:  F A Lederle; G R Johnson; S E Wilson; E P Chute; R J Hye; M S Makaroun; G W Barone; D Bandyk; G L Moneta; R G Makhoul
Journal:  Arch Intern Med       Date:  2000-05-22

4.  The incidence of small abdominal aortic aneurysms and the change in normal infrarenal aortic diameter: implications for screening.

Authors:  A B Wilmink; C S Hubbard; N E Day; C R Quick
Journal:  Eur J Vasc Endovasc Surg       Date:  2001-02       Impact factor: 7.069

5.  Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

Authors:  V J Dzau
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

6.  Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.

Authors:  B Schieffer; E Schieffer; D Hilfiker-Kleiner; A Hilfiker; P T Kovanen; M Kaartinen; J Nussberger; W Harringer; H Drexler
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

7.  Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators.

Authors:  B Keavney; C McKenzie; S Parish; A Palmer; S Clark; L Youngman; M Delépine; M Lathrop; R Peto; R Collins
Journal:  Lancet       Date:  2000-02-05       Impact factor: 79.321

8.  Evaluation of three polymorphisms in the promoter region of the angiotensin II type I receptor gene.

Authors:  X Zhang; J Erdmann; V Regitz-Zagrosek; S Kürzinger; H W Hense; H Schunkert
Journal:  J Hypertens       Date:  2000-03       Impact factor: 4.844

9.  Angiotensinogen concentrations and renin clearance : implications for blood pressure regulation.

Authors:  J Bohlender; J Ménard; D Ganten; F C Luft
Journal:  Hypertension       Date:  2000-03       Impact factor: 10.190

Review 10.  The multiple actions of angiotensin II in atherosclerosis.

Authors:  K M Schmidt-Ott; S Kagiyama; M I Phillips
Journal:  Regul Pept       Date:  2000-09-25
View more
  26 in total

Review 1.  Understanding the pathogenesis of abdominal aortic aneurysms.

Authors:  Helena Kuivaniemi; Evan J Ryer; James R Elmore; Gerard Tromp
Journal:  Expert Rev Cardiovasc Ther       Date:  2015

Review 2.  Unravelling the Lesser Known Facets of Angiotensin II Type 1 Receptor.

Authors:  Mayank Chaudhary; Shashi Chaudhary
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

3.  Genetic risk models: Influence of model size on risk estimates and precision.

Authors:  Ying Shan; Gerard Tromp; Helena Kuivaniemi; Diane T Smelser; Shefali S Verma; Marylyn D Ritchie; James R Elmore; David J Carey; Yvette P Conley; Michael B Gorin; Daniel E Weeks
Journal:  Genet Epidemiol       Date:  2017-02-15       Impact factor: 2.135

Review 4.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

5.  Group X secretory phospholipase A(2) augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice.

Authors:  Melissa Zack; Boris B Boyanovsky; Preetha Shridas; William Bailey; Kathy Forrest; Deborah A Howatt; Michael H Gelb; Frederick C de Beer; Alan Daugherty; Nancy R Webb
Journal:  Atherosclerosis       Date:  2010-08-19       Impact factor: 5.162

6.  Protective effects of angiotensin-converting enzyme I/I and matrix metalloproteinase-3 6A/6A polymorphisms on dilatative pathology within the ascending thoracic aorta.

Authors:  Vaiva Lesauskaite; Giedre Sinkunaite-Marsalkiene; Abdonas Tamosiunas; Rimantas Benetis
Journal:  Eur J Cardiothorac Surg       Date:  2010-12-15       Impact factor: 4.191

7.  Sequence variant on 9p21 is associated with the presence of abdominal aortic aneurysm disease but does not have an impact on aneurysmal expansion.

Authors:  Andrew R Thompson; Jonathan Golledge; Jackie A Cooper; Hany Hafez; Paul E Norman; Steve E Humphries
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

8.  Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection?

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  Int J Hypertens       Date:  2010-08-04       Impact factor: 2.420

9.  Angiotensin-converting enzyme I/D polymorphism and the risk of thoracic aortic dissection in Chinese Han population.

Authors:  Quanmin Jing; Xiaozeng Wang; Yingyan Ma; Ming Yang; Guiqi Huang; Xin Zhao; Yaling Han
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

10.  Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture.

Authors:  Victoria L King; Alexander Y Lin; Fjoralba Kristo; Thomas J T Anderson; Neil Ahluwalia; Gregory J Hardy; A Phillip Owens; Deborah A Howatt; Dongxiao Shen; Andrew M Tager; Andrew D Luster; Alan Daugherty; Robert E Gerszten
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.